A highly subjective list of some of this year's notable young startups

This Durham, North Carolina company just yesterday announced a $3 million seed round to continue working on its microfluidic organoid technology. In this case, the company says its tech creates 10,000 micro tumors from a single cancer biopsy, then tests which cancer treatments will or won't work for a patient -- presumably expediting the time it takes to find the most effective treatment for that person. Who knows, but the company was founded by Duke professors who are also medical oncologists.

https://ift.tt/2PJRF4x from Yahoo Tech https://ift.tt/2EFYqOC
via IFTTT